The Τumor Necrosis Factor-α Converting Enzyme (TACE): A Unique Metalloproteinase with Highly Defined Substrate Selectivity
- 27 June 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 41 (30) , 9462-9469
- https://doi.org/10.1021/bi0260132
Abstract
TNFα converting enzyme (TACE) processes precursor TNFα between Ala76 and Val77, yielding a correctly processed bioactive 17 kDa protein. Genetic evidence indicates that TACE may also be involved in the shedding of other ectodomains. Here we show that native and recombinant forms of TACE efficiently processed a synthetic substrate corresponding to the TNFα cleavage site only. For all other substrates, conversion occurred only at high enzyme concentrations and prolonged reaction times. Often, cleavage under those conditions was accompanied by nonspecific reactions. We also compared TNFα cleavage by TACE to cleavage by those members of the matrix metalloproteinase (MMP) family previously implied in TNFα release. The specificity constants for TNFα cleavage by the MMPs were approximately 100−1000-fold slower relative to TACE. MMP 7 also processed precursor TNFα at the correct cleavage site but did so with a 30-fold lower specificity constant relative to TACE. In contrast, MMP 1 processed precursor TNFα between Ala74 and Gln75, in addition to between Ala76 and Val77, while MMP 9 cleaved this natural substrate solely between Ala74 and Gln75. Additionally, the MMP substrate Dnp-PChaGC(Me)HK(NMA)-NH2 was not cleaved at all by TACE, while collagenase (ΜΜP 1), gelatinase (ΜΜP 9), stromelysin 1 (MMP 3), and matrilysin (MMP 7) all processed this substrate efficiently. All of these results indicate that TACE is unique in terms of its specificity requirements for substrate cleavage.Keywords
This publication has 22 references indexed in Scilit:
- Tumor Necrosis Factor-α Converting Enzyme (TACE) Regulates Epidermal Growth Factor Receptor Ligand AvailabilityJournal of Biological Chemistry, 2002
- Biochemical and Pharmacological Criteria Define Two Shedding Activities for TRANCE/OPGL That Are Distinct from the Tumor Necrosis Factor α ConvertaseJournal of Biological Chemistry, 2001
- Shedding of interleukin‐6 receptor and tumor necrosis factor αEuropean Journal of Biochemistry, 2000
- Specific Sequence Elements Are Required for the Expression of Functional Tumor Necrosis Factor-α-converting Enzyme (TACE)Journal of Biological Chemistry, 1999
- An Essential Role for Ectodomain Shedding in Mammalian DevelopmentScience, 1998
- Evidence That Tumor Necrosis Factor α Converting Enzyme Is Involved in Regulated α-Secretase Cleavage of the Alzheimer Amyloid Protein PrecursorJournal of Biological Chemistry, 1998
- TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3FEBS Letters, 1998
- Pro-Tumor Necrosis Factor-α Processing Activity Is Tightly Controlled by a Component That Does Not Affect Notch ProcessingJournal of Biological Chemistry, 1998
- A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cellsNature, 1997
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987